Market Overview

Syros Pharmaceuticals, Inc. - common stock (SYRS)

9.38 +0.20 (2.18%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/04/20HC Wainwright & Co.UpgradesBuy15.0
3/06/20H.C. WainwrightReiteratesNeutral8.0
1/17/20WedbushDowngradesNeutral9.0
10/18/19JMP SecuritiesMaintainsMarket Outperform16.0
2/14/19OppenheimerAssumesOutperform
3/13/18WedbushMaintainsOutperform13.0
10/31/17PiperJaffrayAssumesOverweight30.0
9/28/17JMP SecuritiesUpgradesMarket Outperform
8/10/17JMP SecuritiesDowngradesMarket Perform
11/29/16OppenheimerInitiates Coverage OnOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter